AI Assisted Personalized Legacy Program (Reflections: My Story) for Patients With Serious Illness
Feasibility and Acceptability of AI Assisted Personalized Legacy Program (Reflections: My Story) for Patients With Serious Illness
1 other identifier
interventional
40
1 country
2
Brief Summary
The purpose of this study is to determine if it is feasible and acceptable to recruit for and deliver the AI Assisted Personalized Legacy Program intervention to patients with serious illness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2025
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 29, 2025
CompletedFirst Posted
Study publicly available on registry
June 6, 2025
CompletedStudy Start
First participant enrolled
August 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
September 16, 2025
September 1, 2025
1.3 years
May 29, 2025
September 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Feasibility Number
Study feasibility will be measured by the number of participants who enrolled and finished the study.
2 years
Acceptability
Acceptability, as measured by the 7-item Was it Worth It (WIWI Questionnaire).The questions are answered as either "yes, no, or uncertain," overall perception of quality of life change, overall perception of study experience, one open-ended feedback question, and an option to talk with someone about concerns. Positive responses indicate acceptability. Results are reported as individual items.
5-10 days post-delivery of the final legacy document
Study Arms (1)
AI Assisted Personalized Legacy Program
EXPERIMENTALInterventions
AI Assisted Personalized Legacy Program will be facilitated by a clinician trained in legacy work.
Eligibility Criteria
You may qualify if:
- Age ≥18 years
- English fluency
- Provide informed consent
- Ability to complete questionnaire(s) by themselves or with assistance
You may not qualify if:
- Other psychological co-morbidities such as untreated schizophrenia, bipolar disease
- Recent suicide attempt or psychiatric illness severe enough that hospitalization has been necessary in last 6 months
- Active delirium
- Advanced dementia
- Participation in concurrent legacy offerings through the palliative care clinic
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (2)
Mayo Clinic
Phoenix, Arizona, 85054, United States
Mayo Clinic
Rochester, Minnesota, 55905, United States
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Deirdre Pachman, MD
Mayo Clinic
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 29, 2025
First Posted
June 6, 2025
Study Start
August 11, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
June 1, 2027
Last Updated
September 16, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share